Funding Opportunities

ONDCP is a government-wide public health and public safety approach to reduce drug use and its consequences. This effort includes a renewed emphasis on community-based prevention programs, early intervention programs, early intervention programs in healthcare settings, aligning criminal justice policies and public health systems to divert non-violent drug offenders into treatment rather than jail, funding scientific research on drug use, and expanding access to substance abuse treatment.

Grant programs include the Drug Free Communities Support Program (DFC), which is the Nation's leading effort to mobilize communities to prevent youth drug use. The DFC program provides grants to local drug-free community coalitions to increase collaboration among community partners to prevent and reduce youth substance abuse.

The DFC program requires funded coalitions to employ environmental strategies in broad initiatives aimed at addressing the entire community through the adaption of policies and practices related to youth substance abuse. In doing so, coalitions can address the environment as a whole and get the most out of available resources.

Since its inception, the DFC program has funded more than 1,600 community coalitions.

An executive branch agency within the Department of Defense, the ONR oversees a portfolio if investments ranging from quick turnaround technologies to long-term basic research.

In FY11, ONR began initiating peer review of ongoing basic research programs across its science and technology departments. Peer review is a process conducted by scientific and technical experts who provide an independent assessment of the scientific merit of research being reviewed. The scientific community depends on peer review to ensure the merit, performance, and relevance of research activities, striving to ensure excellence in the research that is funded.

Open Society Foundations works to build vibrant and tolerant societies whose governments are accountable and open to participation of all people. It also implements initiatives to advance justice, education, public health, and independent media, and helps to shape public policies that assure greater fairness in political, legal, and economic systems, as well as safeguard fundamental rights.

Osteogenesis Imperfecta (OI) is a genetic bone disorder characterized by fragile bones that break easily and is also known as "brittle bone disease." OI is caused by a genetic mutation that affects the body's production of collagen found in bones and other tissues.

Research supported by the OI Foundation includes:

• Michael Geisman Fellowship - A qualified applicant must hold an MD, DDS, DO, or PhD and be appointed at the level of a postdoctoral trainee, or equivalent, within an academic institution. Applicants should have completed their PhD or clinical training within the past five years. Fellowship awards provide up to $50,000 per year which can be used for salary, fringe benefits, and supplies. Research must be done under the supervision of a mentor with training and experience in OI research or research in a related field. Fellowship awards are for one year, a second year of funding may be approved based upon satisfactory performance during the first year of funding.
• Seed Grants for Basic Research - A qualified applicant must hold an MD, DDS, DO, or PhD and have a faculty level appointment within an academic institution. Basic research seed grants provide up to $60,000 for one year, but cannot be used for Principal Investigator salaries or indirect costs.
• Seed Grants for Clinical Research - A qualified applicant must hold an MD, DDS, DO, or PhD and have faculty level appointment within an academic institution or an affiliated health care system. Clinical research seed grants provide up to $120,000 over two years, not including Principal Investigator salaries or indirect costs.

Founded in 1944, this family-run foundation has given more than $121 million in grants to support research directed toward new approaches for cancer treatment and cure as well as financial support for cancer treatment. The Foundation funds research to investigators in US non-profit organizations with the anticipation that this early-stage funding may lead to subsequent and expanded support.

The Foundation encourages grant applications for a one year period which will allow establishment of capabilities by new investigators, or new approaches by established investigators.

An independent nonprofit organization, Pew Charitable Trusts is the sole beneficiary of seven individual charitable funds established between 1948 and 1979 by two sons and two daughters of Sun Oil Co. founder Joseph Newton Pew and his wife, May Anderson Pew.

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public, and stimulate civic life.

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in the first few years of their appointment at the assistant professor level.

Pfizer's Medical & Academic Partnerships program improves patient care and increases the safe and effective use of their medicines. Since the inception of the Medical & Academic Partnerships program in 1984, Pfizer has funded more than 1000 proposals. This program is a reflection of Pfizer's commitment to advancing research, innovation, and medical education in Schools of Medicine, Nursing, Osteopathic Medicine, Pharmacy, and Public Health.

The Prevent Cancer Foundation, a 501(c)3 nonprofit, has been funding cancer prevention research since 1985, and peer-reviewed grants and fellowships have been awarded to nearly 450 early-career scientists from leading academic medical centers nationwide. The Foundation's rigorous selection process is similar to that of the National Institutes of Health.

The Foundation awards research grants and fellowships to promising early-career scientists with novel hypotheses for prevention and early detection. The funding provided through grants and fellowships is arguably one of the most important types of funding to provide. This seed money fosters the next generation of cancer prevention research, creates a strong foundation of preliminary evidence to make scientific advancements and provides the necessary support for researchers to move toward independent research careers.

Firmly committed to curing prostate cancer, the Prostate Cancer Foundation is the leading philanthropic organization funding and accelerating research globally.

Since 1993, PCF has provided unique strategies for identifying and investing in the most promising research programs have generated life-saving results, channeling resources to the world's top scientific minds, cutting red tape and encouraging collaboration to speed breakthroughs.

As a champion for increased government and private support, PCF has helped build a global research enterprise of nearly $10 billion. Through the generous contributions of donors, they have funded more than 1,600 programs at nearly 200 research centers in 16 countries.